Reevaluating the cause of laminopathy in Alzheimer's disease
- PMID: 37056136
- PMCID: PMC10328275
- DOI: 10.4103/1673-5374.367841
Reevaluating the cause of laminopathy in Alzheimer's disease
Conflict of interest statement
None
Figures

References
-
- Alcala-Vida R, Garcia-Forn M, Castany-Pladevall C, Creus-Muncunill J, Ito Y, Blanco E, Golbano A, Crespi-Vazquez K, Parry A, Slater G, Samarajiwa S, Peiro S, Di Croce L, Narita M, Perez-Navarro E. Neuron type-specific increase in lamin B1 contributes to nuclear dysfunction in Huntington's disease. EMBO Mol Med. 2021;13:e12105. - PMC - PubMed
-
- Bahn G, Park JS, Yun UJ, Lee YJ, Choi Y, Baek SH, Choi BY, Cho YS, Kim HK, Han J, Sul JH, Baik SH, Lim J, Wakabayashi N, Bae SH, Han JW, Arumugam TV, Mattson MP, Jo DG. NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models. Proc Natl Acad Sci U S A. 2019;116:12516–12523. - PMC - PubMed
-
- Do Carmo S, Hanzel CE, Jacobs ML, Machnes Z, Iulita MF, Yang J, Yu L, Ducatenzeiler A, Danik M, Breuillaud LS, Bennett DA, Szyf M, Cuello AC. Rescue of early bace-1 and global DNA demethylation by S-adenosylmethionine reduces amyloid pathology and improves cognition in an Alzheimer's model. Sci Rep. 2016;6:34051. - PMC - PubMed
-
- Islam MI, Nagakannan P, Ogungbola O, Djordjevic J, Albensi BC, Eftekharpour E. Thioredoxin system as a gatekeeper in caspase-6 activation and nuclear lamina integrity: implications for Alzheimer's disease. Free Radic Biol Med. 2019;134:567–580. - PubMed
LinkOut - more resources
Full Text Sources